Skip to main content

Main menu

  • Home
  • Current issue
  • ERJ Early View
  • Past issues
  • Authors/reviewers
    • Instructions for authors
    • Submit a manuscript
    • Open access
    • COVID-19 submission information
    • Peer reviewer login
  • Alerts
  • Podcasts
  • Subscriptions
  • ERS Publications
    • European Respiratory Journal
    • ERJ Open Research
    • European Respiratory Review
    • Breathe
    • ERS Books
    • ERS publications home

User menu

  • Log in
  • Subscribe
  • Contact Us
  • My Cart

Search

  • Advanced search
  • ERS Publications
    • European Respiratory Journal
    • ERJ Open Research
    • European Respiratory Review
    • Breathe
    • ERS Books
    • ERS publications home

Login

European Respiratory Society

Advanced Search

  • Home
  • Current issue
  • ERJ Early View
  • Past issues
  • Authors/reviewers
    • Instructions for authors
    • Submit a manuscript
    • Open access
    • COVID-19 submission information
    • Peer reviewer login
  • Alerts
  • Podcasts
  • Subscriptions

Lung function decline in COPD in relation to MMP-12 and surfactant protein A

Annelie Behndig, Robert Linder, Jamshid Pourazar, Anne Lindberg, Anders Blomberg
European Respiratory Journal 2016 48: PA4008; DOI: 10.1183/13993003.congress-2016.PA4008
Annelie Behndig
1Department of Public Health and Clinical Medicine, Medicine, Umeå University, Umeå, Sweden
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Robert Linder
1Department of Public Health and Clinical Medicine, Medicine, Umeå University, Umeå, Sweden
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Jamshid Pourazar
1Department of Public Health and Clinical Medicine, Medicine, Umeå University, Umeå, Sweden
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Anne Lindberg
1Department of Public Health and Clinical Medicine, Medicine, Umeå University, Umeå, Sweden
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Anders Blomberg
1Department of Public Health and Clinical Medicine, Medicine, Umeå University, Umeå, Sweden
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • Article
  • Info & Metrics
Loading

Abstract

Rationale:

Matrix metalloproteinases (MMPs) are of significance in the pathogenesis of COPD. Surfactant proteins (SPs) are involved in immunity and important in the airway defence against infectious agents. We hypothesized that the airway levels of MMPs and SPs would be modified in COPD, in relations to healthy non-smoking individuals, and that COPD patients with more rapid lung function decline would be even further affected.

Methods: 22 patients with COPD were recruited from a population-based cohort (OLIN), (9 with stable lung function (LF), 13 with rapid LF decline; mean yearly FEV1 decline <30 ml and >60 ml respectively), along with 15 smokers and 15 never-smokers with normal LF. Bronchoscopy with bronchial wash (BW 2x20 ml), bronchoalveolar lavage (BAL 3x60 ml) was performed, with quantification of MMP-9, MMP-12, TIMP-1 and Sp-A.

Results: BW and BAL concentrations of MMP-12 were increased in COPD compared with never-smokers; p=0.005 and p=0.005 respectively. In contrast, levels of SP-A were clearly decreased in COPD compared with the control groups; p<0.001 and p<0.001. When comparing responses between COPD-cases with rapid LF decline and stable disease, MMP-12 concentrations were higher in rapid decliners compared to subjects with stable disease. BW and BAL TIMP-1-levels were higher in COPD compared with never-smokers; p=0.008 and p=0.001 respectively.

Conclusions: This study shows evidences of an increased proteolytic activity along with a decreased infectious defence in the COPD airways. As MMP-12 is one of the major proteolytic enzymes to induce airway remodelling in COPD, MMP-12-related lung tissue destruction may be one important mechanism behind rapid lung function loss in COPD.

  • COPD - mechanism
  • Bronchoscopy
  • Immunology
  • Copyright ©the authors 2016
Previous
Back to top
Vol 48 Issue suppl 60 Table of Contents
  • Table of Contents
  • Index by author
Email

Thank you for your interest in spreading the word on European Respiratory Society .

NOTE: We only request your email address so that the person you are recommending the page to knows that you wanted them to see it, and that it is not junk mail. We do not capture any email address.

Enter multiple addresses on separate lines or separate them with commas.
Lung function decline in COPD in relation to MMP-12 and surfactant protein A
(Your Name) has sent you a message from European Respiratory Society
(Your Name) thought you would like to see the European Respiratory Society web site.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Citation Tools
Lung function decline in COPD in relation to MMP-12 and surfactant protein A
Annelie Behndig, Robert Linder, Jamshid Pourazar, Anne Lindberg, Anders Blomberg
European Respiratory Journal Sep 2016, 48 (suppl 60) PA4008; DOI: 10.1183/13993003.congress-2016.PA4008

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero

Share
Lung function decline in COPD in relation to MMP-12 and surfactant protein A
Annelie Behndig, Robert Linder, Jamshid Pourazar, Anne Lindberg, Anders Blomberg
European Respiratory Journal Sep 2016, 48 (suppl 60) PA4008; DOI: 10.1183/13993003.congress-2016.PA4008
del.icio.us logo Digg logo Reddit logo Technorati logo Twitter logo CiteULike logo Connotea logo Facebook logo Google logo Mendeley logo

Jump To

  • Article
  • Info & Metrics
  • Tweet Widget
  • Facebook Like
  • Google Plus One

More in this TOC Section

  • Cryptotanshinone attenuates airway Inflammation induced by cigarette smoke in mice
  • LSC Abstract – Activation of FGF9 and 18 in idiopathic pulmonary fibrosis promote survival and migration and inhibit myofibroblast differentiation of human lung fibroblasts
  • Non-canonical WNT-5A signaling attenuates endogenous lung repair in COPD
Show more 3.3 Mechanisms of Lung Injury and Repair

Related Articles

Navigate

  • Home
  • Current issue
  • Archive

About the ERJ

  • Journal information
  • Editorial board
  • Reviewers
  • Press
  • Permissions and reprints
  • Advertising

The European Respiratory Society

  • Society home
  • myERS
  • Privacy policy
  • Accessibility

ERS publications

  • European Respiratory Journal
  • ERJ Open Research
  • European Respiratory Review
  • Breathe
  • ERS books online
  • ERS Bookshop

Help

  • Feedback

For authors

  • Instructions for authors
  • Publication ethics and malpractice
  • Submit a manuscript

For readers

  • Alerts
  • Subjects
  • Podcasts
  • RSS

Subscriptions

  • Accessing the ERS publications

Contact us

European Respiratory Society
442 Glossop Road
Sheffield S10 2PX
United Kingdom
Tel: +44 114 2672860
Email: journals@ersnet.org

ISSN

Print ISSN:  0903-1936
Online ISSN: 1399-3003

Copyright © 2023 by the European Respiratory Society